Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel W, Hugenberg"'
Publikováno v:
Clinical Pharmacology: Advances and Applications. 12:35-41
Background High on-treatment ADP platelet reactivity (HPR) measured by VerifyNow P2Y12 assay (VN) is an established risk factor for ischemic events after percutaneous coronary intervention (PCI). We hypothesized that routine use of VN at time of PCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::924fcd0528678efcbb2cbd60d4890594
https://doi.org/10.2147/cpaa.s242675
https://doi.org/10.2147/cpaa.s242675
Publikováno v:
Journal of Thrombosis and Thrombolysis. 50:619-627
High on treatment platelet reactivity (HPR) during treatment with clopidogrel has been consistently found to be strong risk factor for recurrent ischemic events after percutaneous coronary intervention (PCI). Insufficient P2Y12 receptor inhibition co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::631c6a83f1417849c3432069071acb31
https://doi.org/10.1007/s11239-020-02075-x
https://doi.org/10.1007/s11239-020-02075-x
Publikováno v:
Journal of thrombosis and thrombolysis. 50(3)
High on treatment platelet reactivity (HPR) during treatment with clopidogrel has been consistently found to be strong risk factor for recurrent ischemic events after percutaneous coronary intervention (PCI). Insufficient P2Y12 receptor inhibition co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8486bc45fc5519751980e7cf56c70434
https://pubmed.ncbi.nlm.nih.gov/32152791
https://pubmed.ncbi.nlm.nih.gov/32152791
Publikováno v:
Clinical Pharmacology : Advances and Applications
Background High on-treatment ADP platelet reactivity (HPR) measured by VerifyNow P2Y12 assay (VN) is an established risk factor for ischemic events after percutaneous coronary intervention (PCI). We hypothesized that routine use of VN at time of PCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27d4306fec41639cdab761b77a8ef41b
https://pubmed.ncbi.nlm.nih.gov/32368161
https://pubmed.ncbi.nlm.nih.gov/32368161
Publikováno v:
Journal of Cardiac Failure. 22:S95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e686cc42736b9977cd19fee10b5782b2
https://doi.org/10.1016/j.cardfail.2016.06.303
https://doi.org/10.1016/j.cardfail.2016.06.303